VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year Sales/Fixed Asset History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Sales/Fixed Asset(x) | 2.67 | 5.04 |
What is the latest Sales/Fixed Asset ratio of VALIANT LABORATORIES ?
Year | Sales/Fixed Asset |
---|---|
Mar2024 | 2.67 |
Mar2023 | 5.04 |
How is Sales/Fixed Asset of VALIANT LABORATORIES Trending?
Years | Sales/Fixed Asset | % Change | |
---|---|---|---|
Mar2024 | 2.67 | -47.02 | |
Mar2023 | 5.04 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Sales/Fixed Asset ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹520.2 Cr | -11.8% | -9.7% | -26.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -11.8% |
-9.7% |
-26.3% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses